Equities

GFC Green Fields Capital Ltd

GFC-M:TLV

GFC Green Fields Capital Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (ILa)1,270.00
  • Today's Change-10.00 / -0.78%
  • Shares traded2.00
  • 1 Year change+29.79%
  • Beta0.1703
Data delayed at least 20 minutes, as of Sep 26 2024 15:24 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

GFC Green Fields Capital Ltd is an Israel-based company, engaged in developing plant traits for the agriculture and biofuel industries, using microRNAs genes. The Company specializes in the identification and use of microRNAs genes that function as ‘main bio-switches’ to control processes in crops, such as corn, wheat, rice, soybean, cotton, canola, and algae. It focuses primarily on developing crops with improved traits for agriculture, such as improved tolerance to environmental stress, improved fertilizer use efficiency, increased yield, improved disease resistance, and increased biofuel productivity. The Company also develops plants with biofuel-related traits, such as castor bean, jatropha, soybean, corn, and sorghum; and algae for the production of bio-ethanol and biodiesel. In addition, it uses microRNA discovery and profiling technologies to identify molecules that are used in marker assisted breeding of crops and traits.

  • Revenue in ILS (TTM)0.00
  • Net income in ILS21.34m
  • Incorporated2010
  • Employees2.00
  • Location
    GFC Green Fields Capital LtdETSEL KANTOR, METSADA 7BNEI BRAK 5126112IsraelISR
  • Phone+972 36133371
  • Fax+972 36133372
  • Websitehttp://www.rosettagreen.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Wilk Technologies Ltd0.00-9.52m30.31m4.00--10.55-----0.1507-0.15070.000.04170.00-------60.36-266.55-71.74-298.65-------97,340.88---30.330.6091------36.02------
Grace Breeding Ltd466.00k-5.21m66.53m----33.18--142.77-1.40-1.300.12450.50030.15980.77181.22---193.35---199.58--80.04---1,210.30--3.49-225.080.00--121.53--23.10------
ICP Israel Citrus Plantations Ltd1.10m4.73m70.11m--16.601.1314.6663.7418.9218.924.40278.020.0123--0.995--5.288.115.528.2771.1870.30430.36521.38----0.00--4.011.78-78.1022.01-60.58--
Crookes Brothers Limited156.82m4.86m111.15m2.00k22.880.50864.470.70881.484.0247.6966.460.392--5.50--2.770.07713.570.0943--49.417.080.21341.924.370.2727--18.221.80112.96-2.49-16.13--
GFC Green Fields Capital Ltd0.0021.34m124.58m2.005.870.73835.84--2.112.110.0016.810.00------4.661.9913.483.58------------0.00------844.9045.32----
Data as of Sep 26 2024. Currency figures normalised to GFC Green Fields Capital Ltd's reporting currency: Israeli Shekel ILS

Institutional shareholders

4.08%Per cent of shares held by top holders
HolderShares% Held
Meitav Mutual Funds Ltd.as of 30 Jun 2024251.18k2.50%
IBI Mutual Funds Management (1978) Ltd.as of 30 Jun 2024158.42k1.58%
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.